Experimental study of action of autostrains Aerococcus viridans on the model Pseudomonas infection
AbstractThe paper presents the results of a study of the action of Aerococcus autostrains on the model of a chronic blue pus infection. For the study of the action of Aerococcus autosymbiont strains on Pseudomonas aeruginosa, three of the most biochemically and antagonistically active isolates were selected: 1) 5m2015 (isolated from mice); 2) 3k2015 (isolated from rats); 3) 3ch2015 (isolated from humans). Experiments were conducted on 84 white outbred mice weighing 16–17 g, 60 were used as the experimental, and 24 as the control group. In the experimental group of animals, infected wounds were treated by Aerococcus autosymbiont strains once daily (0.2 billion ml–1) till recovery. The drug was administered under the scab with a syringe. In the control animals the wound was treated by isotonic sodium chloride solution (concentration 0.9%) with the same route of administration and for the same period of time. It was found that from the very first days of application of Aerococci autosymbiont strains, perifocal inflammation was less severe in most animals in the research group compared with the control group. Starting from the fourth day of usage of Aerococcus autosymbiont strains the number of pseudomonades, contained in secretions from wounds in the experimental group of mice was significantly lower than in the control animals. It was revealed that in case of application of Aerococcus strain (5m2015) isolated from mice, the animals had better indicators of recovery, dynamics of local clinical signs of inflammation and the number of pseudomonades contained in the wound in comparison with other Aerococcus autostrains isolated from rats and humans. The wounds purified from pus and covered with dry scab faster. For example, wounds completely healed with dry scab rejection by the 11th day of observation in 44 of 58 surviving mice (75.9%). In the control group a similar pattern was observed in only 3 of 17 mice (17.6%) by that period. The number of Pseudomonas aeruginosa (equivalent to 1 ml of secretions wounds), expressed in logarithms, was 5.00 ± 0.16 on average on the 4th day in the treated mice, while the control group had the same amount of pseudomonades detected in the wounds (lg 5.22 ± 0.38; lg 5.12 ± 0.30) only on the 13–14th days of observation. We found different activity of strains, depending on the origin of microorganism and type host. Aerococcus viridians autosymbionts showed higher rates in the study of their activity in terms of the blue pus infection model in the treatment of the host and lower activity in treatment.of other species. The obtained data may warrant further study of application of Aerococcus autostrains for treatment and prevention of wound infection caused by pseudomonades.
Campos Furtado, G. H., d’Azevedo, P. A., Santos, A. F., Gales, A. C., Campos Pignatari, A. C., & Servolo Medeiros, E. A. (2007). Intravenous polymyxin B for the treatment of nosocomial pneumonia caused by multidrug-resistant Pseudomonas aeruginosa. International Journal of Antimicrobial Agents, 30(4), 315–319.
Drinka, P., Bonham, P., & Crnich, C. J. (2012). Swab culture of purulent skin infection to detect infection or colonization with antibiotic-resistant bacteria. Journal of the American Medical Directors Association, 13(1), 75−79.
Gupta, A. K., Batra, P., Mathur, P., Karoung, A., Thanbuana, B. T., Thomas, S., Balamurugan, M., Gunjiyal, J., & Misra, M. C. (2015). Microbial epidemio logy and antimicrobial susceptibility profile of wound infections in out-pati ents at a level 1 trauma centre. Journal of Patient Safety and Infection Control, 3(3), 126–129.
Hossam, M. (2016). One year prevalence of critically ill burn wound bacte rial infections in surgical ICU in Egypt: Retrospective study. Egyptian Journal of Anesthesia, 32(3), 431–434.
Il’in, V. K., Suvorov, A. N., & Kirjuhina, N. V. (2013). Autoprobiotiki kak sredstvo profilakti kiinfekcionno-vospalitel’nyh zabolevanij u cheloveka v iskusstvennoj srede obitanija [Autoprobiotics as a prophylactic preparation for infectious–inflammatory diseases in humans in an artificial environment]. Vestnik RAMN, 2, 56–62 (in Russian).
Kremenchutskiy, G. N. (2001). Biological features of A-bacterin. Medichnі Perspektivi, 6(3), 90–97 (in Russian).
Leaper, D., McBain, A. J., & Kramer, A. (2010). Healthcare associated infection: Novel strategies and antimicrobial implants to prevent surgical site infection. Annals of the Royal College of Surgeons of England, 92(6), 453–458.
Lytvyn, L., Quach, K., Banfield, L., Johnston, B. C., & Mertz, D. (2016). Probio tics and synbiotics for the prevention of postoperative infections following abdominal surgery: A systematic review and meta-analysis of randomized controlled trials. Journal of Hospital Infection, 92(2), 130–139.
Marwick, С., Broomhall, J., & Mc Cowan, C. (2011). Severity assessment of skin and soft tissue infections: Cohort study of menegement and outcomes for hospitalized pations. Journal of Antimicrobial Chemotherapy, 66(2), 387−397.
Mc Cay, P. H., Ocampo-Sosa, A. A., & Fleming, G. T. (2010). Effect of subinhi bitory concentrations of benzalkonium chloride on the competitiveness of Pseudomonas aeruginosa grown in continuous culture. Microbiology, 156(1), 30–38.
Narendrа, P. S., Mayuri, R., Kavita, G., Tanu, S., & Iqbal, R. K. (2017). Changing trends in antimicrobial susceptibility pattern of bacterial isolates in a burn unit. Burns, 43(5), 1083–1087.
Nešpor, D., Fabián, J., & Němec, P. (2015). A retrospective analysis of deep sternal wound infections after longitudinal median sternotomy. Coret Vasa, 57(2), e75–e81.
Oliver, A., Mulet, X., Lopez-Causape, C., & Juan, C. (2015). The increasing threat of Pseudomonas aeruginosa high-risk clones. Drug Resist Updates, 21–22, 41–59.
Olveira, G., & González-Molero, I. (2016). An update on probiotics, prebiotics and symbiotics in clinical nutrition. Endocrinología y Nutrición (English Edition), 63(9), 482–494.
Riou, M., Carbonnelle, S., Avrain, L., Mesaros, N., Pirnay, J., Bilocq, F., De Vos, D., Simon, A., Piérard, D., Jacobs, F., Dediste, A., Tulkens, P. M., Van Bam beke, F., & Glupczynski, Y. (2010). In vivo development of antimicrobial resistance in Pseudomonas aeruginosa strains isolated from the lower respi ratory tract of Intensive Care Unit patients with nosocomial pneumonia and receiving antipseudomonal therapy. International Journal of Antimicrobial Agents, 36(6), 513–522.
Shenderov, B. A. (2011). Probiotic (symbiotic) bacteria languages. Anaerobe, 17(6), 490–495.
Shumikhina, I., Sundukova, Z., Solovyeva, O., & Simanenkov, V. (2015). Su1381 autoprobiotic: Place in the prevention of postinfectious irritable bowel syndrome. Gastroenterology, 148(4), S-492.
Simanenkov, V., Suvorov, A., & Sundukova, Z. (2014). Tu1779 Personalized therapy of gastrointestinal diseases with symbiotic bacteria. Gastroenterolo gy, 146(5), S-841.
Suárez, C., Peña, C., Gavaldà, L., Tubau, F., Manzur, A., Dominguez, M. A., Pujol, M., Gudiol, F., & Ariza, J. (2010). Influence of carbapenem resistance on mortality and the dynamics of mortality in Pseudomonas aeruginosa bloodstream infection. International Journal of Infectious Diseases, 14, e73–e78.
Vіl’canjuk, O. A., & Hutorjans’kij, M. O. (2012). Harakteristika zbudnykіv gnіj no-zapal’nih procesіv m’jakih tkanin ta pіsljaoperacіjnih gnіjnih uskladnen’ u hvorih zagal’no-hіrurgіchnogo stacіonaru [Characteristics of pathogens of pus-inflammatory processes in soft tissue and post-operational pus complications in patients of inflammatory-surgical stations]. Pitannja Hіrurgіchnoji Іnfekcіji ta Antibіotikoterapіji, 53, 84−88 (in Ukrainian).
Wei, F., Fengjun, S., Qian, W., Wei, X., Xuewen, Q., Xiaotian, D., & Peiyuan, X. (2017). Epidemiology and resistance characteristics of Pseudomonas aeruginosa isolates from the respiratory department of a hospital in China. Journal of Global Antimicrobial Resistance, 8, 142–147.
Zhou, Z. Y., Hu, B. J., Gao, X. D., Bao, R., Chen, M., & Li, H. Y. (2016). Sources of sporadic Pseudomonas aeruginosa colonizations/infections in surgical ICUs: Association with contaminated sink trap. Journal of Infection and Chemotherapy, 22(7), 450–455.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons «Attribution» 4.0 License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.